Get the Weekly Intelligence Brief — top committee picks every Sunday.

INDV vs ZBH

Indivior Pharmaceuticals Inc vs Zimmer Biomet — AI-powered side-by-side comparison
INDV
Indivior Pharmaceuticals Inc
58
Watch
VS
ZBH
Zimmer Biomet
69
Buy
MetricINDVZBH
AI Score 58 69
Price $38.42 $97.22
P/E Ratio 13.53× 23.54×
ROE -214.3% 5.6%
Revenue Growth YoY
Gross Margin 83.9% 69.9%
Debt / Equity -2.45× 0.59×
Dividend Yield 0.0% 1.0%
RSI (14) 42.6 63.1
Beta 1.0251 0.462
Expected Upside +3.7%

AI Committee View

Current Innellis committee reasoning for INDV versus ZBH.
ZBH leads by 11 points.

ZBH scores 69/100 (Buy) versus INDV at 58/100 (Watch).

INDV Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — high leverage (debt-to-equity 5.43) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • P/E of 12.8 is inexpensive for the broad market — Value
  • ROE of 159.1% shows genuine earnings power backing the valuation — Value
  • EPS growing 237.5% YoY — Growth
Bear Case
  • Price-to-book of 49.6x prices in significant intangible value — Value
  • Debt-to-equity of 5.43 adds balance-sheet risk to the value case — Value
  • MACD histogram negative -- bearish momentum — Technical
ZBH Committee View
80% agreement
5 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend. The committee is constructive but not yet at full conviction.

Bull Case
  • Price-to-book of 1.4x is a discount to asset value — Value
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
INDV Full Analysis ZBH Full Analysis